Drug Biotransformation: Overview

• Understand what is drug biotransformation and how it fundamentally changes drug molecules in your body
• Identify the primary organs involved in drug metabolism, particularly the liver's central role
• Analyze the two-phase system of drug biotransformation and how each phase serves different functions
• Compare Phase I and Phase II reactions in terms of their chemical mechanisms and outcomes
• Recognize how physicochemical properties of drugs influence their biotransformation pathways
• Apply knowledge of drug biotransformation to predict how medications might behave in different patients
• Evaluate the role of microsomal and non-microsomal enzymes in drug metabolism processes
• Explore real-world examples like codeine-to-morphine conversion and acetaminophen metabolism

Understanding Drug Biotransformation Fundamentals

Drug biotransformation represents one of the most critical processes in pharmacology and toxicology. When you take any medication-from over-the-counter pain relievers to prescription antibiotics-your body immediately begins chemically modifying these foreign substances (xenobiotics) through sophisticated enzymatic pathways. This process determines not only how effective your medication will be, but also how long it remains active and whether it might cause harmful side effects.

The primary goal of drug biotransformation is converting lipophilic (fat-loving) drug molecules into hydrophilic (water-loving) compounds that can be easily eliminated through urine or bile. Without this transformation, many drugs would accumulate in fatty tissues indefinitely, potentially reaching toxic levels.

The Two-Phase System of Drug Metabolism

Drug biotransformation occurs through a well-organized two-phase system that maximizes both efficiency and safety. Phase I reactions, also called functionalization reactions, introduce or expose polar functional groups (-OH, -NH2, -SH) through oxidation, reduction, or hydrolysis. The cytochrome P450 enzyme family, particularly CYP3A4 and CYP2D6, dominates Phase I metabolism in liver microsomes. These enzymes can either activate pro-drugs (like codeine to morphine) or begin the inactivation process.

Phase II reactions, known as conjugation reactions, attach small polar molecules like glucuronic acid, sulfate, or glutathione to Phase I products. This conjugation dramatically increases water solubility, making elimination through kidneys much more efficient. For example, acetaminophen (Tylenol) undergoes Phase II glucuronidation and sulfation, creating metabolites that are safely excreted in urine.

Organ Distribution and Clinical Significance

While the liver handles approximately 90% of drug biotransformation, other organs contribute significantly. The lungs metabolize volatile anesthetics, kidneys process certain antibiotics, and intestinal enzymes can inactivate oral medications before they reach systemic circulation-a phenomenon called first-pass metabolism that affects drugs like nitroglycerin and morphine.

Understanding drug biotransformation is crucial for healthcare professionals and appears frequently on MCAT, NCLEX, and pharmacy school examinations. Genetic variations in cytochrome P450 enzymes explain why some patients metabolize medications like warfarin or codeine differently, requiring personalized dosing strategies that prevent adverse drug reactions.